Detection method for determining methyl 3-pyridine sulfonate in Vonoprasan fumarate

By using high performance liquid chromatograph and gradient elution technology in fumarate vonorasan, the problem of cumbersome operation and poor separation effect is solved, and higher detection sensitivity and accuracy are achieved, satisfying the drug safety and quality control requirements.

CN119044352APending Publication Date: 2024-11-29BEIJING YUNPENG PENGCHENG PHARM TECH CO LTD
View PDF 0 Cites 1 Cited by

Patent Information

Application Number
CN202411167473.0
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-23
Publication Date
2024-11-29

AI Technical Summary

Technical Problem

In the prior art, the detection method of methyl 3-pyridine sulfonate in vonorasen fumarate is complicated to operate and has poor separation effect, making it difficult to meet the strict control limit requirements.

Method used

Using a high-performance liquid chromatograph, the mobile phase consists of 0.02mol/L ammonium acetate solution and acetonitrile. The gradient elution technology is used to adjust the proportion of the mobile phase to improve the detection sensitivity and separation effect of impurities, simplifying the preparation process of the mobile phase.

Benefits of technology

It improves the detection sensitivity and accuracy of methyl 3-pyridine sulfonate, reduces the operation difficulty and detection cost, ensures effective separation and control of impurities, and enhances the safety of the drug.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119044352A_ABST
    Figure CN119044352A_ABST
Patent Text Reader

Abstract

The invention relates to the technical field of drug detection, in particular to a method for detecting methyl 3-pyridine sulfonate in Vonoprasone fumarate. The impurity is methyl 3-pyridine sulfonate; the detection method is carried out by using a high performance liquid chromatograph, a mobile phase is composed of a mobile phase A and a mobile phase B, and gradient elution is adopted. The invention provides a method for detecting methyl 3-pyridylsulfonate in Vonoprazan fumarate by adopting a high performance liquid chromatograph according to the structural characteristics of a product and the properties of a compound. According to the present invention, the gradient elution chromatography condition is adopted, the blank solvent does not interfere with the detection of the methyl 3-pyridine sulfonate, the effective separation from the adjacent impurity peak can be achieved, the conditions are optimized, the peak shape is optimized, the detection sensitivity and the accuracy are further improved, the detection is convenient, and the promotion is easy.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of drug detection, and more specifically to a detection method for determining 3-pyridinesulfonic acid methyl ester in vonoprazan fumarate. Background Art

[0002] As a new type of reversible proton pump inhibitor, vonoprazan fumarate has a rapid onset of action compared to traditional irreversible proton pump inhibitors of the prazole type, and can achieve the maximum acid suppression effect on the first day of administration. It can be administered orally, is not affected by gastric acid damage, and does not need to be made into an enteric-coated dosage form. It has a certain improvement effect on the nocturnal acid breakthrough phenomenon and has good tolerability and safety.

[0003] Methyl 3-pyridinesulfonate is a process impurity that may be produced in the synthesis process of vonoprazan fumarate. This impurity has the warning structure of sulfonate and poses a carcinogenic risk. According to ICHM7 requirements, this impurity needs to be strictly controlled. Calculated by the PDE method, the control limit of this impurity should not exceed 75ppm, which is not sensitive enough for conventional detection methods.

[0004] The invention patent with patent application number 202110579058.6 discloses a detection method for simultaneously determining three impurities in vonoprazan fumarate, which uses 0.02-0.05 mol / L potassium dihydrogen phosphate (adjusting the pH to 3-6 with phosphoric acid) as mobile phase A and acetonitrile as mobile phase B. The existing document "Determination of the Content of Genotoxic Impurity Pyridine-3-Sulfonic Acid Methyl Ester in Vonoprazan Fumarate" (Shouguang Fukang Pharmaceutical Co., Ltd., Weifang, Shandong 262700) uses 0.01 mol / L potassium dihydrogen phosphate solution (adjusting the pH to 3.0 with phosphoric acid) as mobile phase A and acetonitrile as mobile phase B.

[0005] The above methods all use potassium dihydrogen phosphate or potassium dihydrogen phosphate solution as the mobile phase, and phosphoric acid is used to adjust the pH, which is cumbersome to operate. In addition, the separation effect of methyl 3-pyridinesulfonate and fumaric acid is average. Summary of the invention

[0006] The present invention aims to solve at least one of the technical problems existing in the prior art. To this end, one aspect of the present invention aims to provide a detection method for determining 3-pyridinesulfonic acid methyl ester in vonoprazan fumarate; the method is more convenient to operate when preparing the mobile phase and can improve the separation effect.

[0007] The mutagenic impurity of the present invention is methyl 3-pyridinesulfonate; the detection method is carried out using a high performance liquid chromatograph, the mobile phase consists of a mobile phase A and a mobile phase B, the mobile phase A is a 0.02 mol / L ammonium acetate solution, and the mobile phase B is acetonitrile; the chemical structural formula of the impurity is as follows:

[0008]

[0009] 3-Pyridinesulfonic acid methyl ester

[0010] Gradient elution was used, and the total volume of the mobile phase was calculated as 100%.

[0011] At 0-7 minutes, the volume of the mobile phase A is 96-98%, and the volume of the mobile phase B is 2-4%;

[0012] At 7-30 minutes, the volume of the mobile phase A decreases from 96-98% to 19-21%, and the volume of the mobile phase B increases from 2-4% to 79-81%;

[0013] At 30-35 minutes, the volume of the mobile phase A is 19-21%, and the volume of the mobile phase B is 79-81%;

[0014] At 35.1 to 45 minutes, the volume of the mobile phase A is 96 to 98%, and the volume of the mobile phase B is 2 to 4%.

[0015] The present invention finds that when high performance liquid chromatography is used to detect 3-pyridine sulfonic acid methyl ester, the selection of mobile phase has a great influence on the detection of impurities. It is found through experiments that when the above elution method is used, the detection sensitivity of 3-pyridine sulfonic acid methyl ester can be significantly improved.

[0016] Preferably, the specific operation steps of the detection method are:

[0017] S1. Test solution: Take an appropriate amount of vonoprazan fumarate, accurately weigh it, dissolve it in a solvent and quantitatively dilute it to make a solution containing 1 mg per 1 ml;

[0018] S2. Reference solution: Take an appropriate amount of 3-pyridinesulfonic acid methyl ester reference substance, accurately weigh it, dissolve it in a solvent and quantitatively dilute it to make a solution containing 0.075 μg per 1 ml;

[0019] S3. Positioning solution: Take an appropriate amount of 3-pyridinesulfonic acid methyl ester reference substance, accurately weigh it, dissolve it in a solvent and quantitatively dilute it to make a solution containing 0.75μg per 1ml;

[0020] S4. Adjust the instrument: the chromatographic column uses octadecylsilane bonded silica gel as the filler, mobile phase A, mobile phase B, adjust the column temperature, adjust the flow rate, and use gradient elution;

[0021] S5. Determination: Accurately measure the solutions prepared in S1 to S3, inject them into the liquid chromatograph respectively, and record the chromatograms.

[0022] Preferably, the concentration of the test solution in S1 is 0.9-1.1 mg / ml.

[0023] Preferably, the concentration of the reference solution in S2 is 0.0675-0.0825 μg / ml.

[0024] Preferably, the concentration of the positioning solution in S3 is 0.675-0.825 μg / ml.

[0025] Preferably, the solvent is acetonitrile-water (1:3).

[0026] Preferably, the chromatographic column in S4 uses octadecylsilane bonded silica gel as a filler, and the specification is VenusilMPC18, 4.6mm×250mm, 5μm.

[0027] Preferably, the column temperature is adjusted to 35-45° C., the flow rate is adjusted to 0.9-1.1 ml / min, and the detection wavelength is adjusted to 265 nm.

[0028] Preferably, the gradient elution is adopted, and the total volume of the mobile phase is calculated as 100%;

[0029] At 0-7 minutes, the volume of the mobile phase A is 97%, and the volume of the mobile phase B is 3%;

[0030] From the 7th to the 30th minute, the volume of the mobile phase A is gradually reduced from 97% to 20%, and the volume of the mobile phase B is gradually increased from 3% to 80%;

[0031] At 30-35 minutes, the volume of the mobile phase A is 20%, and the volume of the mobile phase B is 80%;

[0032] At 35.1 to 45 minutes, the volume of the mobile phase A was 97%, and the volume of the mobile phase B was 3%.

[0033] The beneficial effects of the present invention are as follows:

[0034] The present invention provides a detection method for determining 3-pyridinesulfonic acid methyl ester in vonoprazan fumarate by using a high performance liquid chromatograph according to the product structure characteristics and compound properties. Gradient elution chromatography conditions are adopted, the blank solvent does not interfere with the detection of 3-pyridinesulfonic acid methyl ester, and impurities and vonoprazan fumarate can be effectively separated. By optimizing the conditions, the sensitivity and accuracy of the detection of 3-pyridinesulfonic acid methyl ester are further improved, and the limit requirements are met, and the detection cost and operation difficulty are greatly reduced.

[0035] The mobile phase of the present invention is 0.02 mol / L ammonium acetate solution, and the pH value does not need to be adjusted. When dipotassium hydrogen phosphate or potassium dihydrogen phosphate solution is used as the mobile phase, phosphoric acid needs to be used to adjust the pH. Therefore, the present invention is more convenient to operate when preparing the mobile phase. In the present invention, the retention time of 3-pyridinesulfonic acid methyl ester and fumaric acid is greatly different, and the separation effect between the two is better.

[0036] The method of the present invention adopts simple equipment, fast analysis speed, good specificity, low detection cost, high accuracy, can quickly, simply and accurately control the amount of impurities, and reduce drug safety risks. The method of the present invention has strong specificity and high reproducibility, is convenient for quality detection and impurity monitoring of vonoprazan fumarate, is conducive to the popularization of vonoprazan fumarate impurity detection methods, and is conducive to the safe promotion and application of vonoprazan fumarate.

[0037] Additional aspects and advantages of the invention will become apparent from the following description, or may be learned by practice of the invention. BRIEF DESCRIPTION OF THE DRAWINGS

[0038] The above and / or additional aspects and advantages of the present invention will become apparent and easily understood from the description of the embodiments in conjunction with the following drawings, in which:

[0039] Figure 1 This is the blank solution chromatogram in Example 1 of the present invention.

[0040] Figure 2 It is a chromatogram of the reference substance solution in Example 1 of the present invention.

[0041] Figure 3 This is a chromatogram of the spiked test solution in Example 1 of the present invention. DETAILED DESCRIPTION

[0042] In order to more clearly understand the above-mentioned purpose, features and advantages of the present invention, the present invention is further described in detail below in conjunction with the accompanying drawings and specific embodiments. It should be noted that the embodiments of the present application and the features in the embodiments can be combined with each other without conflict.

[0043] In the following description, many specific details are set forth to facilitate a full understanding of the present invention. However, the present invention may also be implemented in other ways different from the description. Therefore, the protection scope of the present invention is not limited to the specific embodiments disclosed below.

[0044] This embodiment provides a method for detecting 3-pyridinesulfonic acid methyl ester in vonoprazan fumarate using a high performance liquid chromatograph, and the determination is performed under the following conditions:

[0045] Chromatographic column: octadecylsilane bonded silica gel is the filler, the specifications of the chromatographic column are VenusilMPC18, 4.6mm×250mm, 5μm; mobile phase A: 0.02mol / L ammonium acetate solution; mobile phase B: acetonitrile; flow rate: 0.9~1.1ml / min; column temperature: 35~45℃; detection wavelength 265nm; gradient elution is adopted, and the total volume of the mobile phase is 100%.

[0046] At 0-7 minutes, the volume of the mobile phase A is 97%, and the volume of the mobile phase B is 3%;

[0047] From the 7th to the 30th minute, the volume of the mobile phase A is gradually reduced from 97% to 20%, and the volume of the mobile phase B is gradually increased from 3% to 80%;

[0048] At 30-35 minutes, the volume of the mobile phase A is 20%, and the volume of the mobile phase B is 80%;

[0049] At 35.1 to 45 minutes, the volume of the mobile phase A was 97%, and the volume of the mobile phase B was 3%.

[0050] Test solution: Take an appropriate amount of vonoprazan fumarate, weigh accurately, dissolve in solvent and quantitatively dilute to make a solution containing 1 mg per 1 ml.

[0051] Reference solution: Take an appropriate amount of 3-pyridinesulfonic acid methyl ester reference substance, weigh accurately, dissolve in solvent and quantitatively dilute to make a solution containing 0.075 μg per 1 ml.

[0052] Positioning solution: Take an appropriate amount of 3-pyridinesulfonic acid methyl ester reference substance, accurately weigh it, dissolve it in solvent and quantitatively dilute it to make a solution containing 0.75μg per 1ml;

[0053] The specific preparation process of each solution and the experimental verification process and results of the method of the present invention are shown in Experimental Examples 1 to 5.

[0054] Embodiment 1

[0055] Specificity test

[0056] Solvent: acetonitrile-water (1:3)

[0057] Reference solution: Take an appropriate amount of 3-pyridinesulfonic acid methyl ester reference substance, dissolve it with solvent and quantitatively dilute it to make a solution containing about 7.5μg per 1ml as the reference stock solution. Accurately measure 1ml of the reference stock solution, place it in a 100ml volumetric flask, add solvent to dilute to the scale, shake well, and use it as the reference solution.

[0058] Spiked test solution: Take about 100 mg of the product, weigh it accurately, put it in a 100 ml volumetric flask, first add an appropriate amount of solvent to dissolve it, then accurately add 1 ml of the reference stock solution, dilute it to the scale with solvent, shake well, and use it as the spiked test solution.

[0059] Determination: The chromatographic column uses octadecylsilane bonded silica gel as filler, mobile phase A is 0.02 mol / L ammonium acetate solution, mobile phase B is acetonitrile, column temperature is 40°C, flow rate is 1 ml per minute, detection wavelength is 265 nm, and gradient elution is used.

[0060] Accurately measure 50 μl of each of the above solutions and inject them into the HPLC to record the chromatograms. The chromatograms of the blank solvent, reference solution and spiked test solution are shown in Figure 2. Figure 1 to Figure 3 shown.

[0061] Conclusion: The solvent does not interfere with the determination of methyl 3-pyridinesulfonate, and the impurities and the main peak are well separated, meeting the requirements for the determination of related substances.

[0062] Embodiment 2

[0063] Linearity and range tests

[0064] Preparation of linear solution: Take an appropriate amount of 3-pyridinesulfonic acid methyl ester reference substance, accurately weigh it, dissolve it in solvent and quantitatively dilute it to make a solution containing 1.5μg per 1ml as the stock solution. Accurately measure an appropriate amount of the above stock solution and dilute it with solvent to make a series of linear solutions.

[0065] Accurately measure 50 μl of each of the above solutions, inject them into the liquid chromatograph, and record the chromatogram; the results are shown in Table 1.

[0066] Table 1. Linearity and range test results

[0067]

[0068] Conclusion: 3-pyridinesulfonic acid methyl ester has a good linear relationship in the concentration range of 0.019-0.156 μg / ml (equivalent to 0.002%-0.015% of the detection concentration), the linear regression equation is y=62606.2102x-41.1280, r=0.9993, and the percentage of the y-axis intercept equivalent to 100% concentration response value is 0.8%.

[0069] Embodiment 3

[0070] Limit of Quantitation and Limit of Detection Tests

[0071] Quantitation limit solution: Take an appropriate amount of 3-pyridinesulfonic acid methyl ester reference substance, dissolve it in solvent and dilute it to make a solution containing about 0.019μg per 1ml, shake well, and use it as the quantitation limit solution.

[0072] Detection limit solution: Take an appropriate amount of 3-pyridinesulfonic acid methyl ester reference substance, dissolve it in solvent and dilute it to make a solution containing about 0.010μg per 1ml, shake well, and use it as the detection limit solution.

[0073] Accurately measure 50 μl of each of the above solutions and inject them into the liquid chromatograph. The results are shown in Tables 2-3.

[0074] Table 2. Limit of quantitation and limit of detection results

[0075]

[0076] Table 3. Quantitation limit repeatability results

[0077]

[0078] Conclusion: The signal-to-noise ratio of the quantitative limit solution was greater than 10. After 6 repeated injections, the retention time RSD was less than 1.0%, and the peak area RSD was less than 10%. The signal-to-noise ratio of the detection limit solution was greater than 3, and the method had good sensitivity.

[0079] Embodiment 4

[0080] Recovery test

[0081] Reference solution: Take an appropriate amount of 3-pyridinesulfonic acid methyl ester reference substance, dissolve it with solvent and quantitatively dilute it to make a solution containing about 7.5μg per 1ml as the reference stock solution. Accurately measure 1ml of the reference stock solution, place it in a 100ml volumetric flask, add solvent to dilute to the scale, and shake well. Prepare 2 copies in parallel.

[0082] Preparation of accuracy solution:

[0083] 50% accuracy solution: Take about 100 mg of this product, weigh accurately, put it in a 100 ml volumetric flask, add an appropriate amount of solvent to dissolve it, then accurately add 0.5 ml of the reference substance stock solution, dilute to the scale with solvent, shake well, and obtain; prepare 3 copies in parallel.

[0084] 100% accuracy solution: Take about 100 mg of this product, weigh accurately, put it in a 100 ml volumetric flask, add an appropriate amount of solvent to dissolve it, then accurately add 1 ml of the reference substance stock solution, dilute to the scale with solvent, shake well, and obtain; prepare 3 copies in parallel.

[0085] 150% accuracy solution: Take about 100 mg of this product, weigh accurately, put it in a 100 ml volumetric flask, add an appropriate amount of solvent to dissolve it, then accurately add 1.5 ml of the reference substance stock solution, dilute to the scale with solvent, shake well, and obtain; prepare 3 copies in parallel.

[0086] Preparation of background solution:

[0087] Take about 100 mg of this product, weigh accurately, place in a 100 ml volumetric flask, add solvent to dissolve and dilute to the scale, and shake well.

[0088] Accurately measure 50 μl of each of the above solutions and inject them into the liquid chromatograph. The results are shown in Table 4.

[0089] Table 4. Recovery results

[0090]

[0091] Conclusion: The recovery test results showed that the recoveries of the 9 accuracy samples were between 80.0% and 120.0%, and the RSD value of the recovery was less than 10.0%, indicating that the accuracy of this method was good.

[0092] Embodiment 5

[0093] Durability test

[0094] Take the blank solvent, reference solution, and spiked test solution in Experimental Example 1 and conduct the test at column temperatures of 35°C and 45°C and flow rates of 0.9 ml / min and 1.1 ml / min, respectively.

[0095] Conclusion: The blank solvent did not interfere with the detection of methyl 3-pyridinesulfonate by fine-tuning the chromatographic conditions, and the separation between impurities and the main peak met the requirements, indicating that this method has good durability.

[0096] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. For those skilled in the art, the present invention may also have various modifications and variations. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present invention shall be included in the protection scope of the present invention.

Claims

1. A method for determining 3-pyridinesulfonic acid methyl ester in vonoprazan fumarate, characterized in that: The impurity is 3-pyridinesulfonic acid methyl ester; the detection method is carried out using a high performance liquid chromatograph, the mobile phase consists of a mobile phase A and a mobile phase B, the mobile phase A is a 0.02 mol / L ammonium acetate solution, and the mobile phase B is acetonitrile; Gradient elution was used, and the total volume of the mobile phase was calculated as 100%. At 0-7 minutes, the volume of the mobile phase A is 96-98%, and the volume of the mobile phase B is 2-4%; At 7-30 minutes, the volume of the mobile phase A decreases from 96-98% to 19-21%, and the volume of the mobile phase B increases from 2-4% to 79-81%; At 30-35 minutes, the volume of the mobile phase A is 19-21%, and the volume of the mobile phase B is 79-81%; At 35.1 to 45 minutes, the volume of the mobile phase A is 96 to 98%, and the volume of the mobile phase B is 2 to 4%.

2. A method for determining 3-pyridinesulfonic acid methyl ester in vonoprazan fumarate according to claim 1, characterized in that: The specific operation steps of the detection method are: S1. Test solution: Take an appropriate amount of vonoprazan fumarate, accurately weigh it, dissolve it in a solvent and quantitatively dilute it to prepare a test solution; S2. Reference solution: Take an appropriate amount of 3-pyridinesulfonic acid methyl ester reference substance, accurately weigh it, dissolve it in a solvent and quantitatively dilute it to prepare a 3-pyridinesulfonic acid methyl ester reference solution; S3. Positioning solution: Take an appropriate amount of 3-pyridine sulfonic acid methyl ester reference substance, accurately weigh, dissolve in a solvent and quantitatively dilute to prepare 3-pyridine sulfonic acid methyl ester positioning solution; S4. Adjust the instrument: the chromatographic column uses octadecylsilane bonded silica gel as the filler, mobile phase A, mobile phase B, adjust the column temperature, adjust the flow rate, and use gradient elution; S5. Determination: Accurately measure the solutions prepared in S1 to S3, inject them into the liquid chromatograph respectively, and record the chromatograms.

3. A method for determining 3-pyridinesulfonic acid methyl ester in vonoprazan fumarate according to claim 2, characterized in that: The concentration of the test solution in S1 is 0.9-1.1 mg / ml.

4. A method for determining 3-pyridinesulfonic acid methyl ester in vonoprazan fumarate according to claim 2, characterized in that: The concentration of the reference solution in S2 is 0.0675-0.0825 μg / ml.

5. A method for determining 3-pyridinesulfonic acid methyl ester in vonoprazan fumarate according to claim 2, characterized in that: The concentration of the positioning solution in S3 is 0.675-0.825 μg / ml.

6. A method for determining 3-pyridinesulfonic acid methyl ester in vonoprazan fumarate according to any one of claims 2 to 5, characterized in that: The solvent is acetonitrile-water (1:3).

7. A method for determining 3-pyridinesulfonic acid methyl ester in vonoprazan fumarate according to claim 2, characterized in that: The chromatographic column in S4 uses octadecylsilane bonded silica gel as a filler, and the specification is VenusilMPC18, 4.6mm×250mm, 5μm.

8. A method for determining 3-pyridinesulfonic acid methyl ester in vonoprazan fumarate according to claim 2 or 7, characterized in that: The column temperature was adjusted to 35-45°C, the flow rate of the mobile phase was adjusted to 0.9-1.1 ml / min, and the detection wavelength was adjusted to 265 nm.

9. A method for determining 3-pyridinesulfonic acid methyl ester in vonoprazan fumarate according to claim 2, characterized in that: The gradient elution is adopted, and the total volume of the mobile phase is calculated as 100%. At 0-7 minutes, the volume of the mobile phase A is 97%, and the volume of the mobile phase B is 3%; From the 7th to the 30th minute, the volume of the mobile phase A is gradually reduced from 97% to 20%, and the volume of the mobile phase B is gradually increased from 3% to 80%; At 30-35 minutes, the volume of the mobile phase A is 20%, and the volume of the mobile phase B is 80%; At 35.1 to 45 minutes, the volume of the mobile phase A was 97%, and the volume of the mobile phase B was 3%.

Citation Information

Cited By

  • Detection method for determining N-nitroso-Vonoprasan in Vonoprasan fumarate

    CN119827693A